Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:07am, Thursday, 22'nd Jan 2026
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ResMed Inc. (NYSE:RMD) Receives Average Rating of “Moderate Buy” from Brokerages
02:26am, Monday, 19'th Jan 2026
ResMed Inc. (NYSE: RMD - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the sixteen ratings firms that are currently covering the stock, Marketbeat Ratings reports
Bet on These 5 Low-Leverage Stocks to Avoid Industrial Volatilities
10:26am, Thursday, 15'th Jan 2026
Amid dwindling industry-specific volatilities, these five low-leverage stocks stand out as safer bets for investors seeking stability.
Why ResMed (RMD) is a Top Momentum Stock for the Long-Term
10:51am, Tuesday, 13'th Jan 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ResMed Inc. (RMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
06:56pm, Monday, 12'th Jan 2026
ResMed Inc. (RMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Peter Farrell Sells 2,000 Shares of ResMed (NYSE:RMD) Stock
05:28am, Sunday, 11'th Jan 2026
ResMed Inc. (NYSE: RMD - Get Free Report) Director Peter Farrell sold 2,000 shares of the firm's stock in a transaction that occurred on Wednesday, January 7th. The shares were sold at an average pric
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
04:05pm, Thursday, 08'th Jan 2026
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday,
Here's Why ResMed (RMD) is a Strong Growth Stock
10:45am, Thursday, 08'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is This the Right Time to Add Resmed Stock to Your Portfolio?
09:01am, Thursday, 08'th Jan 2026
RMD is seeing rising device demand, expanding international sales and strong liquidity, but macroeconomic pressures could weigh on future performance.
ResMed (NYSE:RMD) General Counsel Michael Rider Sells 50 Shares
05:26am, Tuesday, 06'th Jan 2026
ResMed Inc. (NYSE: RMD - Get Free Report) General Counsel Michael Rider sold 50 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $24
ResMed Inc. $RMD Shares Sold by Chicago Capital LLC
04:32am, Tuesday, 06'th Jan 2026
Chicago Capital LLC cut its holdings in ResMed Inc. (NYSE: RMD) by 14.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,481 share
Railway Pension Investments Ltd Increases Position in ResMed Inc. $RMD
07:21am, Monday, 05'th Jan 2026
Railway Pension Investments Ltd increased its position in shares of ResMed Inc. (NYSE: RMD) by 299.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC
Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:45pm, Tuesday, 30'th Dec 2025
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Buy These 5 Low-Leverage Stocks Amid a Reversal of Santa Claus Rally
09:21am, Tuesday, 30'th Dec 2025
A stalled Santa Claus rally has investors rotating to stability, spotlighting low-leverage names like Resmed that may hold up better amid tech-led volatility.
BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now?
09:21am, Tuesday, 30'th Dec 2025
Boston Scientific edges out Resmed as WATCHMAN momentum, EP gains and acquisitions fuel stronger recent price performance in a growing medical device market.
